A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer: a review of CDK inhibitors

por Fernandes, Mariane Teodoro, Adashek, Jacob J, Barreto, Carmelia Maria Noia, Spinosa, Ana Cláudia Barbin, de Souza Gutierres, Barbara, Lopes, Gilberto, del Giglio, Auro, Aguiar, Pedro Nazareth
Publicado 2018